As of 2025-04-29, the EV/EBITDA ratio of Bolt Biotherapeutics Inc (BOLT) is -0.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BOLT's latest enterprise value is 6.99 mil USD. BOLT's TTM EBITDA according to its financial statements is -66.45 mil USD. Dividing these 2 quantities gives us the above BOLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 12.6x | 10.9x |
| Forward P/E multiples | 13.3x - 19.4x | 18.6x |
| Fair Price | (22.80) - (21.62) | (25.38) |
| Upside | -6257.7% - -5939.3% | -6955.3% |
| Date | EV/EBITDA |
| 2025-04-28 | -0.11 |
| 2025-04-25 | -0.12 |
| 2025-04-24 | -0.12 |
| 2025-04-23 | -0.11 |
| 2025-04-22 | -0.10 |
| 2025-04-21 | -0.09 |
| 2025-04-17 | -0.09 |
| 2025-04-16 | -0.08 |
| 2025-04-15 | -0.09 |
| 2025-04-14 | -0.11 |
| 2025-04-11 | -0.08 |
| 2025-04-10 | -0.08 |
| 2025-04-09 | -0.09 |
| 2025-04-08 | -0.07 |
| 2025-04-07 | -0.09 |
| 2025-04-04 | -0.10 |
| 2025-04-03 | -0.12 |
| 2025-04-02 | -0.12 |
| 2025-04-01 | -0.11 |
| 2025-03-31 | -0.12 |
| 2025-03-28 | -0.14 |
| 2025-03-27 | -0.15 |
| 2025-03-26 | -0.15 |
| 2025-03-25 | -0.13 |
| 2025-03-24 | -0.14 |
| 2025-03-21 | -0.14 |
| 2025-03-20 | -0.15 |
| 2025-03-19 | -0.13 |
| 2025-03-18 | -0.13 |
| 2025-03-17 | -0.13 |
| 2025-03-14 | -0.13 |
| 2025-03-13 | -0.13 |
| 2025-03-12 | -0.12 |
| 2025-03-11 | -0.14 |
| 2025-03-10 | -0.13 |
| 2025-03-07 | -0.14 |
| 2025-03-06 | -0.15 |
| 2025-03-05 | -0.15 |
| 2025-03-04 | -0.15 |
| 2025-03-03 | -0.15 |
| 2025-02-28 | -0.17 |
| 2025-02-27 | -0.17 |
| 2025-02-26 | -0.16 |
| 2025-02-25 | -0.16 |
| 2025-02-24 | -0.17 |
| 2025-02-21 | -0.17 |
| 2025-02-20 | -0.19 |
| 2025-02-19 | -0.18 |
| 2025-02-18 | -0.18 |
| 2025-02-14 | -0.18 |